Erythromycin
DrugSubjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube
NCT Number: NCT00999232
The purpose of this study is to assess the effect of erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube
Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube
Canisius-Wilhelmina Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03253861
Acute Necrotizing Pancreatitis, Digestive System Diseases
Nantes, France
View Trial DetailsNCT07599605
Digestive System Diseases, ERCP
Chihuahua City, Chihuahua, Mexico
View Trial DetailsNCT06721572
Abdominal Pain, Chronic Disease
Ann Arbor, Michigan, United States
View Trial DetailsNCT07381478
Digestive System Diseases, Pancreatic Diseases
Bogotá, Bogota D.C., Colombia
View Trial Details